Source link : https://www.newshealth.biz/health-news/vertex-pauses-islet-cell-study-after-patient-deaths/
Vertex Pharmaceuticals, Inc. has paused a study of its investigational allogeneic stem cell–derived, fully differentiated pancreatic islet cell replacement therapy (VX-880) following two patient deaths. Neither death is related to VX-880, the company said in a January 8, 2024, investor statement, noting that “Vertex has placed the study on a protocol-specified pause, pending review of […]
Author : News Health
Publish date : 2024-01-10 15:07:28
Copyright for syndicated content belongs to the linked Source.